UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019

Therapeutic advances in medical oncology, 2020, Vol.12, p.175883592092863-1758835920928636

Ardalan, Bach

2020

Volltextzugriff (PDF)

Case report: Diagnosis of NUT carcinoma of hepatic origin by next-generation sequencing

Frontiers in oncology, 2024-01, Vol.13, p.1304457

2024

Volltextzugriff (PDF)

Long-Term Survival Based on Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer

The Journal of surgical research, 2017-08, Vol.216, p.65-72

2017

Volltextzugriff (PDF)

Metastatic Pancreatic Adenocarcinoma Downstaged to T0N0 with Chemotherapy and Targeted Therapy, Confirmed by Surgical Pathology: A Case Report

Case reports in oncology, 2024-01, Vol.17 (1), p.803-808

2024

Volltextzugriff (PDF)

Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. . 2019

Therapeutic advances in medical oncology, 2020-06, Vol.12

Bach Ardalan

2020

Volltextzugriff (PDF)

Endoscopic Ultrasound Restaging After Neoadjuvant Chemotherapy in Esophageal Cancer

The American journal of gastroenterology, 2006-06, Vol.101 (6), p.1216-1221

2006

Volltextzugriff (PDF)

In Vitro Global Gene Expression Analyses Support the Ethnopharmacological Use of Achyranthes aspera

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013 (2013), p.1-13

2013

Volltextzugriff (PDF)

Nab-paclitaxel and gemcitabine (modified) in combination with oral cobimetinib and encorafenib following FOLFIRINOX in patients with metastatic G12D and G12V pancreatic cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16330-e16330

2024

Volltextzugriff (PDF)

Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?

The Journal of surgical research, 2012-12, Vol.178 (2), p.623-631

2012

Volltextzugriff (PDF)

Cobimetinib plus gemcitabine is an active combination in KRAS G12R-mutated in previously chemotherapy-treated and failed pancreatic patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4642-4642

2020

Volltextzugriff (PDF)

A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma

Japanese journal of clinical oncology, 2011-04, Vol.41 (4), p.469-476

2011

Volltextzugriff (PDF)

Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Chemotherapies

Journal of pancreatic cancer, 2021-10, Vol.7 (1), p.65-70

2021

Volltextzugriff (PDF)

Neoadjuvant, Surgery and Adjuvant Chemotherapy without Radiation for Esophageal Cancer

Japanese journal of clinical oncology, 2007-08, Vol.37 (8), p.590-596

2007

Volltextzugriff (PDF)

Asymptomatic muscle metastases from esophageal adenocarcinoma

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3780-3783

2007

Volltextzugriff (PDF)

A phase II trial of FUdR in patients with advanced pancreatic cancer

Journal of cancer research and clinical oncology, 2004-10, Vol.130 (10), p.561-566

2004

Volltextzugriff (PDF)

Pancreatic cancer presenting as bowel obstruction and role of next generation sequencing: A case report

International journal of surgery case reports, 2022-01, Vol.90, p.106654-106654, Article 106654

2022

Volltextzugriff (PDF)

Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report

Cold Spring Harbor molecular case studies, 2021-10, Vol.7 (5), p.a006108

2021

Volltextzugriff (PDF)

KRAS G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4150-4150

2023

Volltextzugriff (PDF)

Not all treated KRAS- mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4020-4020

2023

Volltextzugriff (PDF)

In the war against solid tumors arsenic trioxide needs partners

Journal of gastrointestinal cancer, 2014-09, Vol.45 (3), p.363

2014

Volltextzugriff (PDF)

Prognostic indicators of KRAS G12X mutations in pancreatic cancer

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.735-735

2023

Volltextzugriff (PDF)

Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidines

Journal of cancer research and clinical oncology, 2004-08, Vol.130 (8), p.453-459

2004

Volltextzugriff (PDF)

Implementation of hepatic artery infusion (HAI) chemotherapy for unresectable colorectal liver metastases (CRLM): The University of Miami experience

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.96-96

2021

Volltextzugriff (PDF)

In the War Against Solid Tumors Arsenic Trioxide Need Partners

Journal of gastrointestinal cancer, 2014-09, Vol.45 (3), p.363-371

2014

Volltextzugriff (PDF)

Depth of Injury Caused by Liquid Nitrogen Cryospray: Study of Human Patients Undergoing Planned Esophagectomy

Digestive diseases and sciences, 2014-06, Vol.59 (6), p.1296-1301

2014

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(95)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(57)
Humans
(48)
Oncology
(43)
Male
(33)
Female
(32)
Biological And Medical Sciences
(30)
Medical Sciences
(29)
Aged
(23)
Chemotherapy
(23)
Middle Aged
(23)
Pharmacology. Drug Treatments
(23)
Animals
(20)
Antineoplastic Agents
(20)
Adult
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Mice
(18)
Fluorouracil - Administration & Dosage
(16)
Aspartic Acid - Analogs & Derivatives
(13)
Leucovorin - Administration & Dosage
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019

Case report: Diagnosis of NUT carcinoma of hepatic origin by next-generation sequencing

Long-Term Survival Based on Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer

Metastatic Pancreatic Adenocarcinoma Downstaged to T0N0 with Chemotherapy and Targeted Therapy, Confirmed by Surgical Pathology: A Case Report

Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. . 2019

Endoscopic Ultrasound Restaging After Neoadjuvant Chemotherapy in Esophageal Cancer

In Vitro Global Gene Expression Analyses Support the Ethnopharmacological Use of Achyranthes aspera

Nab-paclitaxel and gemcitabine (modified) in combination with oral cobimetinib and encorafenib following FOLFIRINOX in patients with metastatic G12D and G12V pancreatic cancer

Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?

Cobimetinib plus gemcitabine is an active combination in KRAS G12R-mutated in previously chemotherapy-treated and failed pancreatic patients

A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma

Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Chemotherapies

Neoadjuvant, Surgery and Adjuvant Chemotherapy without Radiation for Esophageal Cancer

Asymptomatic muscle metastases from esophageal adenocarcinoma

A phase II trial of FUdR in patients with advanced pancreatic cancer

Pancreatic cancer presenting as bowel obstruction and role of next generation sequencing: A case report

Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report

KRAS G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen

Not all treated KRAS- mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome

In the war against solid tumors arsenic trioxide needs partners

Prognostic indicators of KRAS G12X mutations in pancreatic cancer

Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidines

Implementation of hepatic artery infusion (HAI) chemotherapy for unresectable colorectal liver metastases (CRLM): The University of Miami experience

In the War Against Solid Tumors Arsenic Trioxide Need Partners

Depth of Injury Caused by Liquid Nitrogen Cryospray: Study of Human Patients Undergoing Planned Esophagectomy

Suchergebnisse filtern